United Kingdom · 
What does Ascension Ventures invest in?
Ascension Ventures invests most often at Seed and Series B (55% of the rounds on record), in sectors such as Healthtech, Tech-enabled Health and Wellbeing.
Ascension Ventures highlights
- 01
57 rounds on record
- 02
Mostly Seed and Series B: 55% of its rounds
- 03
Sole investor in 14 rounds, median $310K
- 04
6 exits from the portfolio
What they do
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- $3K – $15M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- HealthtechTech-enabled HealthWellbeing
- Based in
- St. Louis, United Kingdom
- Cold pitches
- Not stated
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first57 appearances
- 2022
1 round
- Mar
- 2019
5 rounds
- Dec
- Aug
- Jul
- May
- Apr
- 2018
2 rounds
- Jul
- Jun
- 2015
11 rounds
- Oct
- Sept
- Sept
- Sept
- Sept
- Sept
- Aug
- Jun
- Mar
- Jan
- Jan
- 2014
6 rounds
- Oct
- Sept
- Apr
- Apr
- Feb
- Jan
- 2013
16 rounds
- Dec
- Oct
- Aug
- Aug
- Jul
- Jul
- Jul
- Jun
- Jun
- May
- Apr
- Apr
- Apr
- Apr
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
AJAnthony James SperanzoDirectoriForm ADV
ARAnthony Rocco TersigniDirectoriForm ADV
JRJoseph Raymond ImpiccicheDirectoriForm ADV
We also hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$475Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- AHV Holding Company, LLC
- SEC number
- CRD 161371
Exits from the portfolio
Companies it backed that were later bought or listed6 in all
NaviHealthBought by Cardinal Health$410MAug 2015
EpitherapeuticsBought by Gilead Sciences$65MMay 2015
EKOS CorporationBought by BTG$220MMay 2013
BodyMediaBought by Jawbone$100MApr 2013
HemosphereBought by CryoLife$22MMay 2012
BioImageneBought by Roche$100MAug 2010
An exit counts when it came after the firm's first round in the company. From historical deal records.